Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05726526

CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients

Led by University of Manitoba · Updated on 2026-03-09

340

Participants Needed

5

Research Sites

300 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The main purpose of this trial is to determine whether the addition of the VIEWER virtual care platform to usual care will lead to a reduction in composite emergency department (ED) visits and/or hospitalizations/or increase the perceived safety of virtual care among patients and providers.

CONDITIONS

Official Title

CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Over 18 years of age
  • Patient or caregiver can read and speak English
  • Patient or substitute decision maker able to provide informed consent
  • Patient or caregiver able and willing to use the VIEWER mobile app and perform self-measurements
  • Have stage 5 CKD with two eGFR measurements below 15 ml/min/1.73m2 or over 40% chance of starting dialysis in 2 years
  • Receiving care in a multidisciplinary CKD clinic
Not Eligible

You will not qualify if you...

  • Unable to perform self-monitoring or caregiver-assisted monitoring using the VIEWER platform

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

St. Boniface Hospital

Winnipeg, Manitoba, Canada, R2H 2A6

Actively Recruiting

2

Chronic Disease Innovation Centre, Seven Oaks Hospital

Winnipeg, Manitoba, Canada, R2V 3M3

Actively Recruiting

3

Health Sciences Centre

Winnipeg, Manitoba, Canada, R3A 1R9

Actively Recruiting

4

London Health Sciences Centre

London, Ontario, Canada, N6A 5W9

Actively Recruiting

5

Scarborough Health Network - General Hospital

Scarborough Village, Ontario, Canada, M1P 2V5

Actively Recruiting

Loading map...

Research Team

C

Claudio Rigatto, MD

CONTACT

Z

Zahra Solati, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here